BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34058115)

  • 1. In COPD, prophylactic macrolides, but not tetracyclines or quinolones, reduce exacerbations, with fewer serious adverse events.
    Adams SG; Peters JI
    Ann Intern Med; 2021 Jun; 174(6):JC66. PubMed ID: 34058115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
    Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
    Herath SC; Poole P
    Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease.
    Donath E; Chaudhry A; Hernandez-Aya LF; Lit L
    Respir Med; 2013 Sep; 107(9):1385-92. PubMed ID: 23768735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term macrolide therapy at low doses in stable COPD.
    Cao Y; Xuan S; Wu Y; Yao X
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1289-1298. PubMed ID: 31354258
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotic prophylaxis in COPD: Why, when, and for whom?
    Miravitlles M; Anzueto A
    Pulm Pharmacol Ther; 2015 Jun; 32():119-23. PubMed ID: 24825753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic antibiotic therapy in chronic obstructive pulmonary disease.
    Herath SC; Poole P
    JAMA; 2014 Jun; 311(21):2225-6. PubMed ID: 24893090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide antibiotics for prevention of chronic obstructive pulmonary disease exacerbations: are we there yet?
    Restrepo MI; Anzueto A
    Am J Respir Crit Care Med; 2014 Jul; 190(1):1-2. PubMed ID: 24983214
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative effectiveness of macrolides and quinolones for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
    Rothberg MB; Pekow PS; Lahti M; Brody O; Skiest DJ; Lindenauer PK
    J Hosp Med; 2010; 5(5):261-7. PubMed ID: 20533570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and meta-analysis of prophylactic antibiotics in COPD and/or chronic bronchitis.
    Lee JS; Park DA; Hong Y; Jo KW; Lee SW; Huh JW; Oh YM; Lee SD
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):153-62. PubMed ID: 23317949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis.
    Ni W; Shao X; Cai X; Wei C; Cui J; Wang R; Liu Y
    PLoS One; 2015; 10(3):e0121257. PubMed ID: 25812085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are prophylactic antibiotics useful in chronic obstructive pulmonary disease?
    Arenas A; Rada G
    Medwave; 2015 Nov; 15 Suppl 3():e6309. PubMed ID: 26571418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials.
    Wang Y; Zijp TR; Bahar MA; Kocks JWH; Wilffert B; Hak E
    J Antimicrob Chemother; 2018 Dec; 73(12):3231-3243. PubMed ID: 30189002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics as immunomodulant agents in COPD.
    Blasi F; Mantero M; Aliberti S
    Curr Opin Pharmacol; 2012 Jun; 12(3):293-9. PubMed ID: 22321568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis.
    Siempos II; Dimopoulos G; Korbila IP; Manta K; Falagas ME
    Eur Respir J; 2007 Jun; 29(6):1127-37. PubMed ID: 17301097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing COPD exacerbations with macrolides: a review and budget impact analysis.
    Simoens S; Laekeman G; Decramer M
    Respir Med; 2013 May; 107(5):637-48. PubMed ID: 23352223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease.
    Wilson R; Sethi S; Anzueto A; Miravitlles M
    J Infect; 2013 Dec; 67(6):497-515. PubMed ID: 23973659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease.
    Qiu S; Zhong X
    Ther Adv Respir Dis; 2017 Mar; 11(3):147-155. PubMed ID: 28030992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide therapy for the prevention of acute exacerbations in chronic obstructive pulmonary disease.
    Mammen MJ; Sethi S
    Pol Arch Med Wewn; 2012; 122(1-2):54-9. PubMed ID: 22353707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.